Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Triple Targeting in DLBCL: BR101801 and Venetoclax Synergy
2026-05-25
This study demonstrates that co-targeting c-Myc, Bcl-2, and Mcl-1 using BR101801 and Venetoclax yields a synergistic antitumor effect in double-hit diffuse large B-cell lymphoma (DLBCL) models. The findings highlight the limitations of Bcl-2 inhibition alone and suggest a promising combinatorial approach for overcoming resistance in aggressive lymphoma subtypes.
-
Streptavidin-Cy3: Precision Biotin Detection in Cancer Metas
2026-05-25
Streptavidin-Cy3 stands out as a robust biotin detection reagent, enabling high-sensitivity visualization of biotinylated molecules in advanced cancer research. Its optimized conjugation and bright Cy3 fluorescence empower researchers to dissect complex phenomena like super-enhancer RNA-driven metastasis with clarity and reproducibility.
-
CHIR-99021 (CT99021): GSK-3 Inhibition for Translational Imp
2026-05-24
Explore how CHIR-99021 (CT99021) advances stem cell research and translational science by uniting mechanistic precision with actionable strategy. This article synthesizes molecular insights, protocol optimization, and clinical outlooks to empower researchers bridging bench to bedside.
-
Z-WEHD-FMK (SKU A1924): Data-Driven Solutions for Caspase Pa
2026-05-23
This in-depth article addresses key laboratory challenges in cell viability and inflammation assays, demonstrating how Z-WEHD-FMK (SKU A1924) offers reproducible, data-backed solutions for caspase pathway studies. By anchoring protocol optimization and product selection in published evidence, this guide empowers biomedical researchers, lab technicians, and postgraduates to troubleshoot caspase-1/4/5 inhibition and workflow reproducibility with confidence.
-
CPI-613: Unlocking Mitochondrial Vulnerabilities in Tumors
2026-05-22
This thought-leadership article explores CPI-613’s disruption of pyruvate and alpha-ketoglutarate dehydrogenase in tumor cell mitochondria, its implications for apoptosis and ferroptosis resistance, and how translational researchers can leverage these insights for more effective acute myeloid leukemia and non-small cell lung carcinoma models. Drawing on recent advances in mitochondrial calcium signaling and referencing the latest literature, the article provides mechanistic clarity, workflow recommendations, and a strategic outlook for future cancer metabolism research.
-
Cycloheximide as a Precision Protein Biosynthesis Inhibitor
2026-05-22
Cycloheximide delivers unmatched experimental control for dissecting translation-dependent processes, from apoptosis assays to viral replication studies. APExBIO’s research-grade formulation ensures reproducibility and flexibility across advanced cell and animal models, empowering researchers with actionable protocols and troubleshooting strategies.
-
Deferasirox Fe3+ Chelate: Reliable Tool for Iron Overload St
2026-05-21
This article explores real-world laboratory scenarios where Deferasirox Fe3+ chelate (SKU A3355) provides robust, reproducible solutions in iron overload treatment research. Leveraging literature-backed insights and workflow optimization, we detail practical strategies for cell viability, proliferation, and cytotoxicity assays using this high-purity, DMSO-soluble iron chelator.
-
Cell Line and Reporter Selection in mRNA-LNP Transfection As
2026-05-21
Zhen et al. (2025) systematically evaluated how cell line and reporter gene selection impact the reproducibility and quantitative accuracy of in vitro mRNA-LNP transfection assays. Their findings emphasize that both biological context and assay design critically determine the reliability of mRNA delivery and expression measurements, guiding optimization in translational mRNA research.
-
Steroid-Induced Protoplast Lysis: Mechanisms and CXCR4 Pathw
2026-05-20
This article reviews Smith and Shay's 1965 investigation into how synthetic steroids induce lysis in bacterial protoplasts, revealing direct membrane actions and the modulating effects of various stabilizers and antagonists. These findings provide a foundational model for studying membrane-targeting agents, including contemporary CXCR4 antagonists, and aid in optimizing experimental workflows for anti-HIV and chemokine pathway research.
-
Thiazovivin (A5506): Practical Guidance for ROCK Inhibition
2026-05-20
Thiazovivin is a high-purity ROCK inhibitor that addresses common challenges in stem cell research by enhancing induced pluripotent stem cell generation and safeguarding human embryonic stem cell survival post-dissociation. It is well-suited for workflows requiring increased cell viability during reprogramming or passaging but should not be used for diagnostic or therapeutic purposes.
-
Caspofungin in Advanced Antifungal Assays: Mechanisms and Im
2026-05-19
Explore Caspofungin, a lipopeptide antifungal drug, through a rigorous analysis of its molecular mechanisms and cutting-edge assay applications. This article uniquely unpacks new insights from recent comparative studies and offers actionable guidance for researchers addressing azole-resistant Candida.
-
Syringin Natural Product: Advanced Workflows for Bioactive S
2026-05-19
Syringin’s ability to modulate EGFR/PI3K/Akt signaling and enhance sunitinib response sets it apart as a precision tool in apoptosis and drug resistance research. This article translates recent mechanistic findings into actionable protocols and troubleshooting strategies for applied natural product research.
-
Mubritinib–HSA Recognition: Implications for Protein–Drug In
2026-05-18
This study delineates how Mubritinib, a mitochondrial ETC inhibitor, binds human serum albumin (HSA) with moderate affinity, altering both HSA structure and function. These findings provide a blueprint for understanding protein–drug interactions essential for optimizing the pharmacokinetics of anti-proliferative agents like 2-[4-(2-methylpropyl)phenyl]propanoic acid (Ibuprofen) in cancer research.
-
Fluorescein TSA Fluorescence System Kit: Beyond Sensitivity
2026-05-18
Discover how the Fluorescein TSA Fluorescence System Kit enables ultra-sensitive detection of biomolecules in neuroscience and molecular biology. This article offers a deep scientific dive into its mechanisms, practical advantages, and unique relevance for advanced neurobiological assays.
-
Syringin Natural Product: Precision Assay Design and Researc
2026-05-17
Explore the advanced research applications and precise assay design enabled by the Syringin natural product. Learn how Syringin’s unique properties and mechanistic insights support cutting-edge bioactive compound screening beyond standard RCC studies.